Association of Interleukin-12 Polymorphisms and Serum IL-12p40 Levels with Osteosarcoma Risk
- 1 October 2013
- journal article
- research article
- Published by SAGE Publications in DNA and Cell Biology
- Vol. 32 (10) , 605-610
Abstract
No previous studies reported the association of IL-12 polymorphisms with osteosarcoma. We aimed to investigate the association in a Chinese population. IL-12A rs568408, rs2243115, and IL-12B rs3212227 polymorphisms were evaluated in a case–control study of 106 osteosarcoma patients and 210 health controls by using polymerase chain reaction–restriction fragment length polymorphism. Serum IL-12p40 levels were measured by enzyme-linked immunosorbent assay. The serum IL-12p40 levels were significantly higher in controls than those in osteosarcoma patients (pp=0.035). Stratification analysis showed no associations between rs3212227 variant and the patients' gender, tumor location, and metastasis. Our data suggest that the serum IL-12p40 levels associate with the risk of osteosarcoma and are regulated by IL-12B rs3212227 polymorphism. The IL-12A rs568408 and IL-12B rs3212227 may confer the susceptibility to osteosarcoma risk.Keywords
This publication has 33 references indexed in Scilit:
- Association of IL-12, IL-18 variants and serum IL-18 with bladder cancer susceptibility in North Indian populationGene, 2013
- Interactions of IL-12A and IL-12B Polymorphisms on the Risk of Cervical Cancer in Chinese WomenClinical Cancer Research, 2008
- Contribution of IL‐12R mediated feedback loop to Th1 cell differentiationFEBS Letters, 2007
- Interleukin-12: Biological Properties and Clinical ApplicationClinical Cancer Research, 2007
- Cytokine Gene Polymorphisms, Cancer Susceptibility, and Prognosis ,The Journal of Nutrition, 2007
- Intranasal interleukin‐12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastasesCancer, 2006
- CD1d-restricted “NKT” cells and myeloid IL-12 production: an immunological crossroads leading to promotion or suppression of effective anti-tumor immune responses?Journal of Leukocyte Biology, 2004
- Direct Interaction of Major Histocompatibility Complex Class II-derived Peptides with Class Ia Phosphoinositide 3-Kinase Results in Dose-dependent Stimulatory EffectsJournal of Biological Chemistry, 2004
- The roles of IFNγ in protection against tumor development and cancer immunoeditingCytokine & Growth Factor Reviews, 2002
- Bone cancersCancer, 1995